<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35893119</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>28</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2076-3271</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Jul</Month><Day>14</Day></PubDate></JournalIssue><Title>Medical sciences (Basel, Switzerland)</Title><ISOAbbreviation>Med Sci (Basel)</ISOAbbreviation></Journal><ArticleTitle>The Use of Palmitoylethanolamide in the Treatment of Long COVID: A Real-Life Retrospective Cohort Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">37</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/medsci10030037</ELocationID><Abstract><AbstractText>COVID-19 can cause symptoms that last weeks or months after the infection has gone, with a significant impairment of quality of life. Palmitoylethanolamide (PEA) is a naturally occurring lipid mediator that has an entourage effect on the endocannabinoid system mitigating the cytokine storm. The aim of this retrospective study is to evaluate the potential efficacy of PEA in the treatment of long COVID. Patients attending the Neurological Out Clinic of the IRCCS Centro Neurolesi Bonino-Pulejo (Messina, Italy) from August 2020 to September 2021 were screened for potential inclusion in the study. We included only long COVID patients who were treated with PEA 600 mg two times daily for about 3 months. All patients performed the post-COVID-19 Functional Status (PCFS) scale. Thirty-three patients (10 males, 43.5%, mean age 47.8 &#xb1; 12.4) were enrolled in the study. Patients were divided into two groups based on hospitalization or home care observation. A substantial difference in the PCFS score between the two groups at baseline and after treatment with PEA were found. We found that smoking was a risk factor with an odds ratio of 8.13 CI 95% [0.233, 1.167]. Our findings encourage the use of PEA as a potentially effective therapy in patients with long COVID.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Raciti</LastName><ForeName>Loredana</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-0564-2320</Identifier><AffiliationInfo><Affiliation>GCA-Centro Spoke AO Cannizzaro, Catania, IRCCS Centro Neurolesi Bonino Pulejo, 98123 Messina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Luca</LastName><ForeName>Rosaria</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Behavioral and Robotic Neurorehabilitation Unit, IRCCS Centro Neurolesi Bonino Pulejo, 98123 Messina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raciti</LastName><ForeName>Gianfranco</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>GCA-Centro Spoke AO Cannizzaro, Catania, IRCCS Centro Neurolesi Bonino Pulejo, 98123 Messina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arcadi</LastName><ForeName>Francesca Antonia</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Behavioral and Robotic Neurorehabilitation Unit, IRCCS Centro Neurolesi Bonino Pulejo, 98123 Messina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calabr&#xf2;</LastName><ForeName>Rocco Salvatore</ForeName><Initials>RS</Initials><Identifier Source="ORCID">0000-0002-8566-3166</Identifier><AffiliationInfo><Affiliation>Behavioral and Robotic Neurorehabilitation Unit, IRCCS Centro Neurolesi Bonino Pulejo, 98123 Messina, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Med Sci (Basel)</MedlineTA><NlmUniqueID>101629322</NlmUniqueID><ISSNLinking>2076-3271</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000577">Amides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004983">Ethanolamines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010169">Palmitic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>6R8T1UDM3V</RegistryNumber><NameOfSubstance UI="C005958">palmidrol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000577" MajorTopicYN="N">Amides</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004983" MajorTopicYN="N">Ethanolamines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010169" MajorTopicYN="N">Palmitic Acids</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000093485" MajorTopicYN="Y">COVID-19 Drug Treatment</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">PEA</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">persistent post-COVID syndrome</Keyword><Keyword MajorTopicYN="N">post-COVID-19 functional status scale</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. </CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>6</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>27</Day><Hour>4</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35893119</ArticleId><ArticleId IdType="pmc">PMC9326613</ArticleId><ArticleId IdType="doi">10.3390/medsci10030037</ArticleId><ArticleId IdType="pii">medsci10030037</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Roncati L., Manenti A., Manco G., Farinetti A. Abdominal Aortic Thrombosis Complicating COVID-19 Pneumonia. Ann. Vasc. Surg. 2020;67:8&#x2013;9. doi: 10.1016/j.avsg.2020.05.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.avsg.2020.05.033</ArticleId><ArticleId IdType="pmc">PMC7255212</ArticleId><ArticleId IdType="pubmed">32473304</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholls J.M., Poon L.L., Lee K.C., Ng W.F., Lai S.T., Leung C.Y., Chu C.M., Hui P.K., Mak K.L., Lim W., et al. Lung pathology of fatal severe acute respiratory syndrome. Lancet. 2003;361:1773&#x2013;1778. doi: 10.1016/S0140-6736(03)13413-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(03)13413-7</ArticleId><ArticleId IdType="pmc">PMC7112492</ArticleId><ArticleId IdType="pubmed">12781536</ArticleId></ArticleIdList></Reference><Reference><Citation>Barreca G., Bonforte A., Neri M. A pilot GIS database of active faults of Mt. Etna (Sicily): A tool for integrated hazard evaluation. J. Volcanol. Geotherm. Res. 2013;251:170&#x2013;186. doi: 10.1016/j.jvolgeores.2012.08.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvolgeores.2012.08.013</ArticleId></ArticleIdList></Reference><Reference><Citation>NIHR  Living with COVID-19. A Dynamic Review of the Evidence Around Ongoing COVID-19 Symptoms (Often Called Long COVID) 2020.  [(accessed on 15 May 2022)].  Available online:  https://evidence.nihr.ac.uk/themedreview/living-with-covid19.</Citation></Reference><Reference><Citation>Raciti L., Calabr&#xf2; R.S. Can volcanic trace elements facilitate COVID-19 diffusion? A hypothesis stemming from the Mount Etna area, Sicily. Med. Hypotheses. 2020;144:110058. doi: 10.1016/j.mehy.2020.110058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110058</ArticleId><ArticleId IdType="pmc">PMC7320851</ArticleId><ArticleId IdType="pubmed">32758894</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P., McAuley D.F., Brown M., Sanchez E., Tattersall R.S., Manson J.J., HLH Across Speciality Collaboration COVID-19: Consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033&#x2013;1034. doi: 10.1016/S0140-6736(20)30628-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30628-0</ArticleId><ArticleId IdType="pmc">PMC7270045</ArticleId><ArticleId IdType="pubmed">32192578</ArticleId></ArticleIdList></Reference><Reference><Citation>Roncati L., Manenti A., Manco G., Farinetti A., Mattioli A. The COVID-19 Arterial Thromboembolic Complications: From Inflammation to Immunothrombosis Through Antiphospholipid Autoantibodies. Ann. Vasc. Surg. 2021;72:216&#x2013;217. doi: 10.1016/j.avsg.2020.12.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.avsg.2020.12.006</ArticleId><ArticleId IdType="pmc">PMC7837102</ArticleId><ArticleId IdType="pubmed">33387619</ArticleId></ArticleIdList></Reference><Reference><Citation>Temerozo J.R., Fintelman-Rodrigues N., Dos Santos M.C., Hottz E.D., Sacramento C.Q., de Paula Dias da Silva A., Mandacaru S.C., Dos Santos Moraes E.C., Trugilho M.R.O., Gesto J.S.M., et al. Human endogenous retrovirus K in the respiratory tract is associated with COVID-19 physiopathology. Microbiome. 2022;10:65. doi: 10.1186/s40168-022-01260-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-022-01260-9</ArticleId><ArticleId IdType="pmc">PMC9024070</ArticleId><ArticleId IdType="pubmed">35459226</ArticleId></ArticleIdList></Reference><Reference><Citation>Giacomelli A., Pezzati L., Conti F., Bernacchia D., Siano M., Oreni L., Rusconi S., Gervasoni C., Ridolfo A.L., Rizzardini G., et al. Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study. Clin. Infect. Dis. 2020;71:889&#x2013;890. doi: 10.1093/cid/ciaa330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa330</ArticleId><ArticleId IdType="pmc">PMC7184514</ArticleId><ArticleId IdType="pubmed">32215618</ArticleId></ArticleIdList></Reference><Reference><Citation>Raciti L., Arcadi F.A., Calabr&#xf2; R.S. Could Palmitoylethanolamide Be an Effective Treatment for Long-COVID-19? Hypothesis and Insights in Potential Mechanisms of Action and Clinical Applications. Innov. Clin. Neurosci. 2022;19:19&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8970234</ArticleId><ArticleId IdType="pubmed">35382075</ArticleId></ArticleIdList></Reference><Reference><Citation>Rigoni M., Torri E., Nollo G., Donne L.D., Rizzardo S., Lenzi L., Falzone A., Cozzio S. &#x201c;Long COVID&#x201d; results after hospitalization for SARS-CoV-2 infection. Sci. Rep. 2022;12:9581. doi: 10.1038/s41598-022-13077-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-13077-5</ArticleId><ArticleId IdType="pmc">PMC9185134</ArticleId><ArticleId IdType="pubmed">35688830</ArticleId></ArticleIdList></Reference><Reference><Citation>Wulf Hanson S., Abbafati C., Aerts J.G., Al-Aly Z., Ashbaugh C., Ballouz T., Blyuss O., Bobkova P., Bonsel G., Borzakova S., et al. A global systematic analysis of the occurrence, severity, and recovery pattern of long COVID in 2020 and 2021. medRxiv. 2022 doi: 10.1101/2022.05.26.22275532. in preprint .</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.05.26.22275532</ArticleId></ArticleIdList></Reference><Reference><Citation>A Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus. 6 October 2021.  [(accessed on 5 November 2021)].  Available online:  https://www.who.int/publications-detail-redirect/WHO-2019-nCoV-Post_COVID.</Citation></Reference><Reference><Citation>Biradar V., Moran J.L.  SIRS, Sepsis and Multiorgan Failure. In: Fitridge R., Thompson M., editors. Mechanisms of Vascular Disease: A Reference Book for Vascular Specialists. University of Adelaide Press; Adelaide, Australia: 2011.  [(accessed on 17 May 2022)].  Internet; Adelaide (AU) Available online:  https://www.ncbi.nlm.nih.gov/books/NBK534275/</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamers L., Kox M., Pickkers P. Sepsis-induced immunoparalysis: Mechanisms, markers, and treatment options. Minerva Anestesiol. 2015;81:426&#x2013;439.</Citation><ArticleIdList><ArticleId IdType="pubmed">24878876</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrin L.B., Weinstock L.B., Molderings G.J. COVID-19 hyperinflammation and post-COVID-19 illness may be rooted in mast cell activation syndrome. Int. J. Infect. Dis. 2020;100:327&#x2013;332. doi: 10.1016/j.ijid.2020.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.09.016</ArticleId><ArticleId IdType="pmc">PMC7529115</ArticleId><ArticleId IdType="pubmed">32920235</ArticleId></ArticleIdList></Reference><Reference><Citation>Kritas S.K., Ronconi G., Caraffa A., Gallenga C.E., Ross R., Conti P. Mast cells contribute to coronavirus-induced inflammation: New anti-inflammatory strategy. J. Biol. Regul. Homeost. Agents. 2020;34:9&#x2013;14. doi: 10.23812/20-Editorial-Kritas.</Citation><ArticleIdList><ArticleId IdType="doi">10.23812/20-Editorial-Kritas</ArticleId><ArticleId IdType="pubmed">32013309</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X., Chu H., Wong B.H., Chiu M.C., Wang D., Li C., Liu X., Yang D., Poon V.K., Cai J., et al. Activation of C-Type Lectin Receptor and (RIG)-I-Like Receptors Contributes to Proinflammatory Response in Middle East Respiratory Syndrome Coronavirus-Infected Macrophages. J. Infect. Dis. 2020;221:647&#x2013;659. doi: 10.1093/infdis/jiz483.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiz483</ArticleId><ArticleId IdType="pmc">PMC7107474</ArticleId><ArticleId IdType="pubmed">31562757</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung S.Y., Yuen K.S., Ye Z.W., Chan C.P., Jin D.Y. A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: Lessons from other pathogenic viruses. Emerg. Microbes Infect. 2020;9:558&#x2013;570. doi: 10.1080/22221751.2020.1736644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1736644</ArticleId><ArticleId IdType="pmc">PMC7103735</ArticleId><ArticleId IdType="pubmed">32172672</ArticleId></ArticleIdList></Reference><Reference><Citation>von Moltke J., Trinidad N.J., Moayeri M., Kintzer A.F., Wang S.B., van Rooijen N., Brown C.R., Krantz B.A., Leppla S.H., Gronert K., et al. Rapid induction of inflammatory lipid mediators by the inflammasome in vivo. Nature. 2012;490:107&#x2013;111. doi: 10.1038/nature11351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11351</ArticleId><ArticleId IdType="pmc">PMC3465483</ArticleId><ArticleId IdType="pubmed">22902502</ArticleId></ArticleIdList></Reference><Reference><Citation>Gartung A., Yang J., Sukhatme V.P., Bielenberg D.R., Fernandes D., Chang J., Schmidt B.A., Hwang S.H., Zurakowski D., Huang S., et al. Suppression of chemotherapy-induced cytokine/lipid mediator surge and ovarian cancer by a dual COX-2/sEH inhibitor. Proc. Natl. Acad. Sci. USA. 2019;116:1698&#x2013;1703. doi: 10.1073/pnas.1803999116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1803999116</ArticleId><ArticleId IdType="pmc">PMC6358686</ArticleId><ArticleId IdType="pubmed">30647111</ArticleId></ArticleIdList></Reference><Reference><Citation>Serhan C.N. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014;510:92&#x2013;101. doi: 10.1038/nature13479.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13479</ArticleId><ArticleId IdType="pmc">PMC4263681</ArticleId><ArticleId IdType="pubmed">24899309</ArticleId></ArticleIdList></Reference><Reference><Citation>Panigrahy D., Gilligan M.M., Huang S., Gartung A., Cort&#xe9;s-Puch I., Sime P.J., Phipps R.P., Serhan C.N., Hammock B.D. Inflammation resolution: A dual-pronged approach to averting cytokine storms in COVID-19? Cancer Metastasis Rev. 2020;39:337&#x2013;340. doi: 10.1007/s10555-020-09889-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10555-020-09889-4</ArticleId><ArticleId IdType="pmc">PMC7207990</ArticleId><ArticleId IdType="pubmed">32385712</ArticleId></ArticleIdList></Reference><Reference><Citation>Kr&#xf6;ger H., Donner I., Skiello G. Influence of a new virostatic compound on the induction of enzymes in rat liver. Arzneimittelforschung. 1975;25:1426&#x2013;1429.</Citation><ArticleIdList><ArticleId IdType="pubmed">24</ArticleId></ArticleIdList></Reference><Reference><Citation>Gigante A., Aquili A., Farinelli L., Caraffa A., Ronconi G., Enrica Gallenga C., Tet&#xe8; G., Kritas S.K., Conti P. Sodium chromo-glycate and palmitoylethanolamide: A possible strategy to treat mast cell-induced lung inflammation in COVID-19. Med. Hypotheses. 2020;143:109856. doi: 10.1016/j.mehy.2020.109856.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.109856</ArticleId><ArticleId IdType="pmc">PMC7236677</ArticleId><ArticleId IdType="pubmed">32460208</ArticleId></ArticleIdList></Reference><Reference><Citation>Roncati L., Nasillo V., Lusenti B., Riva G. Signals of Th2 immune response from COVID-19 patients requiring intensive care. Ann. Hematol. 2020;99:1419&#x2013;1420. doi: 10.1007/s00277-020-04066-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00277-020-04066-7</ArticleId><ArticleId IdType="pmc">PMC7205481</ArticleId><ArticleId IdType="pubmed">32382776</ArticleId></ArticleIdList></Reference><Reference><Citation>Roncati L., Vadal&#xe0; M., Corazzari V., Palmieri B. COVID-19 vaccine and boosted immunity: Nothing ad interim to do? Vaccine. 2020;38:7581&#x2013;7584. doi: 10.1016/j.vaccine.2020.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2020.10.013</ArticleId><ArticleId IdType="pmc">PMC7546174</ArticleId><ArticleId IdType="pubmed">33071005</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z., Shi L., Wang Y., Zhang J., Huang L., Zhang C., Liu S., Zhao P., Liu H., Zhu L., et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir. Med. 2020;8:420&#x2013;422. doi: 10.1016/S2213-2600(20)30076-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30076-X</ArticleId><ArticleId IdType="pmc">PMC7164771</ArticleId><ArticleId IdType="pubmed">32085846</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma B.K., Kakker N.K., Bhadouriya S., Chhabra R. Effect of TLR agonist on infections bronchitis virus replication and cytokine expression in embryonated chicken eggs. Mol. Immunol. 2020;120:52&#x2013;60. doi: 10.1016/j.molimm.2020.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2020.02.001</ArticleId><ArticleId IdType="pmc">PMC7112572</ArticleId><ArticleId IdType="pubmed">32065987</ArticleId></ArticleIdList></Reference><Reference><Citation>Boi R., Ebefors K., Henricsson M., Bor&#xe9;n J., Nystr&#xf6;m J. Modified lipid metabolism and cytosolic phospholipase A2 activation in mesangial cells under pro-inflammatory conditions. Sci. Rep. 2022;12:7322. doi: 10.1038/s41598-022-10907-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-10907-4</ArticleId><ArticleId IdType="pmc">PMC9072365</ArticleId><ArticleId IdType="pubmed">35513427</ArticleId></ArticleIdList></Reference><Reference><Citation>Barksdale C., Kipper F.C., Tripathy S., Subbian S., Serhan C.N., Panigrahy D. COVID-19 and cancer: Start the resolution! Cancer Metastasis Rev. 2022;41:1&#x2013;15. doi: 10.1007/s10555-021-10017-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10555-021-10017-z</ArticleId><ArticleId IdType="pmc">PMC8860263</ArticleId><ArticleId IdType="pubmed">35190921</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimeno-Almaz&#xe1;n A., Pallar&#xe9;s J.G., Buend&#xed;a-Romero &#xc1;., Mart&#xed;nez-Cava A., Franco-L&#xf3;pez F., S&#xe1;nchez-Alcaraz Mart&#xed;nez B.J., Bernal-Morel E., Courel-Ib&#xe1;&#xf1;ez J. Post-COVID-19 Syndrome and the Potential Benefits of Exercise. Int. J. Environ. Res. Public Health. 2021;18:5329. doi: 10.3390/ijerph18105329.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18105329</ArticleId><ArticleId IdType="pmc">PMC8156194</ArticleId><ArticleId IdType="pubmed">34067776</ArticleId></ArticleIdList></Reference><Reference><Citation>Onaivi E.S., Sharma V. Cannabis for COVID-19: Can cannabinoids quell the cytokine storm? Future Sci. OA. 2020;6:FSO625. doi: 10.2144/fsoa-2020-0124.</Citation><ArticleIdList><ArticleId IdType="doi">10.2144/fsoa-2020-0124</ArticleId><ArticleId IdType="pmc">PMC7451410</ArticleId><ArticleId IdType="pubmed">32974048</ArticleId></ArticleIdList></Reference><Reference><Citation>Impellizzeri D., Bruschetta G., Cordaro M., Crupi R., Siracusa R., Esposito E., Cuzzocrea S. Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain. J. Neuroinflamm. 2014;11:136. doi: 10.1186/s12974-014-0136-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-014-0136-0</ArticleId><ArticleId IdType="pmc">PMC4171547</ArticleId><ArticleId IdType="pubmed">25164769</ArticleId></ArticleIdList></Reference><Reference><Citation>Curci C., Pisano F., Bonacci E., Camozzi D.M., Ceravolo C., Bergonzi R., De Franceschi S., Moro P., Guarnieri R., Ferrillo M., et al. Early rehabilitation in post-acute COVID-19 patients: Data from an Italian COVID-19 Rehabilitation Unit and proposal of a treatment protocol. Eur. J. Phys. Rehabil. Med. 2020;56:633&#x2013;641. doi: 10.23736/S1973-9087.20.06339-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S1973-9087.20.06339-X</ArticleId><ArticleId IdType="pubmed">32667150</ArticleId></ArticleIdList></Reference><Reference><Citation>Maresca G., De Cola M.C., Caliri S., De Luca R., Manuli A., Scarcella I., Silvestri G., Bramanti P., Torrisi M., Calabr&#xf2; R.S., et al. Moving towards novel multidisciplinary approaches for improving elderly quality of life: The emerging role of telemedicine in Sicily. J. Telemed. Telecare. 2018;25:318&#x2013;324. doi: 10.1177/1357633X17753057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1357633X17753057</ArticleId><ArticleId IdType="pubmed">29409381</ArticleId></ArticleIdList></Reference><Reference><Citation>Maresca G., Maggio M.G., De Luca R., Manuli A., Tonin P., Pignolo L., Calabr&#xf2; R. Tele-NeuroRehabilitation in Italy: State of the Art and Future Perspectives. Front. Neurol. 2020;11:563375. doi: 10.3389/fneur.2020.563375.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.563375</ArticleId><ArticleId IdType="pmc">PMC7554582</ArticleId><ArticleId IdType="pubmed">33101176</ArticleId></ArticleIdList></Reference><Reference><Citation>Oronsky B., Larson C., Hammond T.C., Oronsky A., Kesari S., Lybeck M., Reid T.R. A Review of Persistent Post-COVID Syndrome (PPCS) Clin. Rev. Allergy Immunol. 2021;20:1&#x2013;9. doi: 10.1007/s12016-021-08848-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-021-08848-3</ArticleId><ArticleId IdType="pmc">PMC7896544</ArticleId><ArticleId IdType="pubmed">33609255</ArticleId></ArticleIdList></Reference><Reference><Citation>Muscogiuri G., Barrea L., Savastano S., Colao A. Nutritional recommendations for CoVID-19 quarantine. Eur. J. Clin. Nutr. 2020;74:850&#x2013;851. doi: 10.1038/s41430-020-0635-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41430-020-0635-2</ArticleId><ArticleId IdType="pmc">PMC7155155</ArticleId><ArticleId IdType="pubmed">32286533</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribeiro A.L.R., Sousa N.W.A., Carvalho V.O. What to do when the choice is no choice at all? A critical view on nutritional recommendations for CoVID-19 quarantine. Eur. J. Clin. Nutr. 2020;74:1488&#x2013;1489. doi: 10.1038/s41430-020-00722-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41430-020-00722-3</ArticleId><ArticleId IdType="pmc">PMC7427493</ArticleId><ArticleId IdType="pubmed">32796923</ArticleId></ArticleIdList></Reference><Reference><Citation>Gigli S., Seguella L., Pesce M., Bruzzese E., D&#x2019;Alessandro A., Cuomo R., Steardo L., Sarnelli G., Esposito G. Cannabidiol restores intestinal barrier dysfunction and inhibits the apoptotic process induced by Clostridium difficile toxin A in Caco-2 cells. United Eur. Gastroenterol. J. 2017;5:1108&#x2013;1115. doi: 10.1177/2050640617698622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2050640617698622</ArticleId><ArticleId IdType="pmc">PMC5721977</ArticleId><ArticleId IdType="pubmed">29238589</ArticleId></ArticleIdList></Reference><Reference><Citation>Pesce M., Esposito G., Sarnelli G. Endocannabinoids in the treatment of gasytrointestinal inflammation and symptoms. Curr. Opin. Pharmacol. 2018;43:81&#x2013;86. doi: 10.1016/j.coph.2018.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coph.2018.08.009</ArticleId><ArticleId IdType="pubmed">30218940</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganley O.H., Graessle O.E., Robinson H.J. Anti-inflammatory activity on compounds obtained from egg yolk, peanut oil, and soybean lecithin. J. Lab. Clin. Med. 1958;51:709&#x2013;714.</Citation><ArticleIdList><ArticleId IdType="pubmed">13539486</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambert D.M., Di Marzo V. The palmitoylethanolamide and oleamide enigmas: Are these two fatty acid amides cannabimimetic? Curr. Med. Chem. 1999;6:757&#x2013;773. doi: 10.2174/0929867306666220401153732.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0929867306666220401153732</ArticleId><ArticleId IdType="pubmed">10469890</ArticleId></ArticleIdList></Reference><Reference><Citation>Ardizzone A., Fusco R., Casili G., Lanza M., Impellizzeri D., Esposito E., Cuzzocrea S. Effect of Ultra-Micronized-Palmitoylethanolamide and Acetyl-l-Carnitine on Experimental Model of Inflammatory Pain. Int. J. Mol. Sci. 2021;22:1967. doi: 10.3390/ijms22041967.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22041967</ArticleId><ArticleId IdType="pmc">PMC7922157</ArticleId><ArticleId IdType="pubmed">33671213</ArticleId></ArticleIdList></Reference><Reference><Citation>Keppel Hesselink J.M., de Boer T., Witkamp R.F. Palmitoylethanolamide: A Natural Body-Own Anti-Inflammatory Agent, Effective and Safe against Influenza and Common Cold. Int. J. Inflamm. 2013;2013:151028. doi: 10.1155/2013/151028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/151028</ArticleId><ArticleId IdType="pmc">PMC3771453</ArticleId><ArticleId IdType="pubmed">24066256</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti P., Caraffa A., Tet&#xe8; G., Gallenga C.E., Ross R., Kritas S.K., Frydas I., Younes A., Di Emidio P., Ronconi G. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19. J. Biol. Regul. Homeost. Agents. 2020;34:1629&#x2013;1632. doi: 10.23812/20-2EDIT.</Citation><ArticleIdList><ArticleId IdType="doi">10.23812/20-2EDIT</ArticleId><ArticleId IdType="pubmed">32945158</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran A.V. Long COVID-19: Challenges in the diagnosis and proposed diagnostic criteria. Diabetes Metab. Syndr. 2021;15:145&#x2013;146. doi: 10.1016/j.dsx.2020.12.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.12.025</ArticleId><ArticleId IdType="pmc">PMC7737559</ArticleId><ArticleId IdType="pubmed">33341598</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegerink B., Rohmann J.L. Impact of your results: Beyond the relative risk. Res. Pract. Thromb. Haemost. 2018;2:653&#x2013;657. doi: 10.1002/rth2.12148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rth2.12148</ArticleId><ArticleId IdType="pmc">PMC6178613</ArticleId><ArticleId IdType="pubmed">30349882</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok F.A., Boon G.J.A.M., Barco S., Endres M., Geelhoed J.J.M., Knauss S., Rezek S.A., Spruit M.A., Vehreschild J., Siegerink B. The Post-COVID-19 Functional Status scale: A tool to measure functional status over time after COVID-19. Eur. Respir. J. 2020;56:2001494. doi: 10.1183/13993003.01494-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01494-2020</ArticleId><ArticleId IdType="pmc">PMC7236834</ArticleId><ArticleId IdType="pubmed">32398306</ArticleId></ArticleIdList></Reference><Reference><Citation>Aloe L., Leon A., Levi-Montalcini R. A proposed autacoid mechanism controlling mastocyte behaviour. Agents Actions. 1993;39:C145&#x2013;C147. doi: 10.1007/BF01972748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01972748</ArticleId><ArticleId IdType="pubmed">7505999</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y., Xu X., Chen Z., Duan J., Hashimoto K., Yang L., Liu C., Yang C. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav. Immun. 2020;87:18&#x2013;22. doi: 10.1016/j.bbi.2020.03.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.03.031</ArticleId><ArticleId IdType="pmc">PMC7146689</ArticleId><ArticleId IdType="pubmed">32240762</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo Verme J., Fu J., Astarita G., La Rana G., Russo R., Calignano A., Piomelli D. The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide. Mol. Pharmacol. 2005;67:15&#x2013;19. doi: 10.1124/mol.104.006353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/mol.104.006353</ArticleId><ArticleId IdType="pubmed">15465922</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarnelli G., Gigli S., Capoccia E., Iuvone T., Cirillo C., Seguella L., Nobile N., D&#x2019;Alessandro A., Pesce M., Steardo L., et al. Palmitoylethanolamide Exerts Antiproliferative Effect and Downregulates VEGF Signaling in Caco-2 Human Colon Carcinoma Cell Line Through a Selective PPAR-&#x3b1;-Dependent Inhibition of Akt/mTOR Pathway. Phytother. Res. 2016;30:963&#x2013;970. doi: 10.1002/ptr.5601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.5601</ArticleId><ArticleId IdType="pubmed">26929026</ArticleId></ArticleIdList></Reference><Reference><Citation>Roncati L., Gallo G., Manenti A., Palmieri B. Renin-angiotensin system: The unexpected flaw inside the human immune system revealed by SARS-CoV-2. Med. Hypotheses. 2020;140:109686. doi: 10.1016/j.mehy.2020.109686.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.109686</ArticleId><ArticleId IdType="pmc">PMC7118521</ArticleId><ArticleId IdType="pubmed">32220710</ArticleId></ArticleIdList></Reference><Reference><Citation>Godlewski G., Offert&#xe1;ler L., Wagner J.A., Kunos G. Receptors for acylethanolamides-GPR55 and GPR119. Prostaglandins Other Lipid Mediat. 2009;89:105&#x2013;111. doi: 10.1016/j.prostaglandins.2009.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.prostaglandins.2009.07.001</ArticleId><ArticleId IdType="pmc">PMC2751869</ArticleId><ArticleId IdType="pubmed">19615459</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho W.S., Barrett D.A., Randall M.D. &#x2018;Entourage&#x2019; effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors. Br. J. Pharmacol. 2008;155:837&#x2013;846. doi: 10.1038/bjp.2008.324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/bjp.2008.324</ArticleId><ArticleId IdType="pmc">PMC2597234</ArticleId><ArticleId IdType="pubmed">18695637</ArticleId></ArticleIdList></Reference><Reference><Citation>Pesce M., Seguella L., Cassarano S., Aurino L., Sanseverino W., Lu J., Corpetti C., Del Re A., Vincenzi M., Sarnelli G., et al. Phytotherapics in COVID19: Why palmitoylethanolamide? Phytother. Res. 2021;35:2514&#x2013;2522. doi: 10.1002/ptr.6978.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.6978</ArticleId><ArticleId IdType="pubmed">33296131</ArticleId></ArticleIdList></Reference><Reference><Citation>Wheal A.J., Alexander S.P., Randall M.D. Hydrogen peroxide as a mediator of vasorelaxation evoked by N-oleoylethanolamine and anandamide in rat small mesenteric arteries. Eur. J. Pharmacol. 2012;674:384&#x2013;390. doi: 10.1016/j.ejphar.2011.11.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2011.11.033</ArticleId><ArticleId IdType="pubmed">22154756</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarnelli G., D&#x2019;Alessandro A., Iuvone T., Capoccia E., Gigli S., Pesce M., Seguella L., Nobile N., Aprea G., Maione F., et al. Palmitoylethanolamide Modulates Inflammation-Associated Vascular Endothelial Growth Factor (VEGF) Signaling via the Akt/mTOR Pathway in a Selective Peroxisome Proliferator-Activated Receptor Alpha (PPAR-&#x3b1;)-Dependent Manner. PLoS ONE. 2016;11:e0156198. doi: 10.1371/journal.pone.0156198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0156198</ArticleId><ArticleId IdType="pmc">PMC4878779</ArticleId><ArticleId IdType="pubmed">27219328</ArticleId></ArticleIdList></Reference><Reference><Citation>Magadum A., Engel F.B. PPAR&#x3b2;/&#x3b4;: Linking Metabolism to Regeneration. Int. J. Mol. Sci. 2018;19:2013. doi: 10.3390/ijms19072013.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19072013</ArticleId><ArticleId IdType="pmc">PMC6073704</ArticleId><ArticleId IdType="pubmed">29996502</ArticleId></ArticleIdList></Reference><Reference><Citation>Korbecki J., Bobi&#x144;ski R., Dutka M. Self-regulation of the inflammatory response by peroxisome proliferator-activated receptors. Inflamm. Res. 2019;68:443&#x2013;458. doi: 10.1007/s00011-019-01231-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-019-01231-1</ArticleId><ArticleId IdType="pmc">PMC6517359</ArticleId><ArticleId IdType="pubmed">30927048</ArticleId></ArticleIdList></Reference><Reference><Citation>Cipriano M., Esposito G., Negro L., Capoccia E., Sarnelli G., Scuderi C., De Filippis D., Steardo L., Iuvone T. Palmitoylethanolamide Regulates Production of Pro-Angiogenic Mediators in a Model of &#x3b2; Amyloid-Induced Astrogliosis In Vitro. CNS Neurol. Disord. Drug Targets. 2015;14:828&#x2013;837. doi: 10.2174/1871527314666150317224155.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1871527314666150317224155</ArticleId><ArticleId IdType="pubmed">25801844</ArticleId></ArticleIdList></Reference><Reference><Citation>Lama A., Provensi G., Amoriello R., Pirozzi C., Rani B., Mollica M.P., Raso G.M., Ballerini C., Meli R., Passani M.B. The anti-inflammatory and immune-modulatory effects of OEA limit DSS-induced colitis in mice. Biomed. Pharmacother. 2020;129:110368. doi: 10.1016/j.biopha.2020.110368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2020.110368</ArticleId><ArticleId IdType="pubmed">32559625</ArticleId></ArticleIdList></Reference><Reference><Citation>Cua D.J., Sherlock J., Chen Y., Murphy C.A., Joyce B., Seymour B., Lucian L., To W., Kwan S., Churakova T., et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature. 2003;421:744&#x2013;748. doi: 10.1038/nature01355.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature01355</ArticleId><ArticleId IdType="pubmed">12610626</ArticleId></ArticleIdList></Reference><Reference><Citation>Couch D.G., Tasker C., Theophilidou E., Lund J.N., O&#x2019;Sullivan S.E. Cannabidiol and palmitoylethanolamide are anti-inflammatory in the acutely inflamed human colon. Clin. Sci. 2017;131:2611&#x2013;2626. doi: 10.1042/CS20171288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20171288</ArticleId><ArticleId IdType="pubmed">28954820</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker J.M., Krey J.F., Chu C.J., Huang S.M. Endocannabinoids and related fatty acid derivatives in pain modulation. Chem. Phys. Lipids. 2002;121:159&#x2013;172. doi: 10.1016/S0009-3084(02)00152-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0009-3084(02)00152-4</ArticleId><ArticleId IdType="pubmed">12505698</ArticleId></ArticleIdList></Reference><Reference><Citation>Heide E.C., Bindila L., Post J.M., Malzahn D., Lutz B., Seele J., Nau R., Ribes S. Prophylactic Palmitoylethanolamide Prolongs Survival and Decreases Detrimental Inflammation in Aged Mice With Bacterial Meningitis. Front. Immunol. 2018;9:2671. doi: 10.3389/fimmu.2018.02671.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02671</ArticleId><ArticleId IdType="pmc">PMC6250830</ArticleId><ArticleId IdType="pubmed">30505308</ArticleId></ArticleIdList></Reference><Reference><Citation>Scuderi C., Esposito G., Blasio A., Valenza M., Arietti P., Steardo LJr Carnuccio R., De Filippis D., Petrosino S., Iuvone T., Di Marzo V., et al. Palmitoylethanolamide counteracts reactive astrogliosis induced by &#x3b2;-amyloid peptide. J. Cell. Mol. Med. 2011;15:2664&#x2013;2674. doi: 10.1111/j.1582-4934.2011.01267.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1582-4934.2011.01267.x</ArticleId><ArticleId IdType="pmc">PMC4373435</ArticleId><ArticleId IdType="pubmed">21255263</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarnelli G., Seguella L., Pesce M., Lu J., Gigli S., Bruzzese E., Lattanzi R., D&#x2019;Alessandro A., Cuomo R., Steardo L., et al. HIV-1 Tat-induced diarrhea is improved by the PPARalpha agonist, palmitoylethanolamide, by suppressing the activation of enteric glia. J. Neuroinflamm. 2018;15:94. doi: 10.1186/s12974-018-1126-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-018-1126-4</ArticleId><ArticleId IdType="pmc">PMC5866515</ArticleId><ArticleId IdType="pubmed">29573741</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Stadio A., D&#x2019;Ascanio L., Vaira L.A., Cantone E., De Luca P., Cingolani C., Motta G., De Riu G., Vitelli F., Spriano G., et al. Ultramicronized Palmitoylethanolamide and Luteolin Supplement Combined with Olfactory Training to Treat Post-COVID-19 Olfactory Impairment: A Multi-Center Double-Blinded Randomized Placebo-Controlled Clinical Trial. Curr. Neuropharmacol. 2022 doi: 10.2174/1570159X20666220420113513.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1570159X20666220420113513</ArticleId><ArticleId IdType="pmc">PMC9886808</ArticleId><ArticleId IdType="pubmed">35450527</ArticleId></ArticleIdList></Reference><Reference><Citation>Fonnesu R., Thunuguntla V.B.S.C., Veeramachaneni G.K., Bondili J.S., La Rocca V., Filipponi C., Spezia P.G., Sidoti M., Plicanti E., Quaranta P., et al. Palmitoylethanolamide (PEA) Inhibits SARS-CoV-2 Entry by Interacting with S Protein and ACE-2 Receptor. Viruses. 2022;14:1080. doi: 10.3390/v14051080.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14051080</ArticleId><ArticleId IdType="pmc">PMC9146540</ArticleId><ArticleId IdType="pubmed">35632821</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Agostino G., Russo R., Avagliano C., Cristiano C., Meli R., Calignano A. Palmitoylethanolamide protects against the amyloid-&#x3b2;25-35-induced learning and memory impairment in mice, an experimental model of Alzheimer disease. Neuropsychopharmacology. 2012;37:1784&#x2013;1792. doi: 10.1038/npp.2012.25.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/npp.2012.25</ArticleId><ArticleId IdType="pmc">PMC3358748</ArticleId><ArticleId IdType="pubmed">22414817</ArticleId></ArticleIdList></Reference><Reference><Citation>Patanavanich R., Glantz S.A. Smoking Is Associated With COVID-19 Progression: A Meta-analysis. Nicotine Tob. Res. 2020;22:1653&#x2013;1656. doi: 10.1093/ntr/ntaa082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ntr/ntaa082</ArticleId><ArticleId IdType="pmc">PMC7239135</ArticleId><ArticleId IdType="pubmed">32399563</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann V.O., Carerj M.L., Wieters I., Fahim M., Arendt C., Hoffmann J., Shchendrygina A., Escher F., Vasa-Nicotera M., Zeiher A.M., et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19) JAMA Cardiol. 2020;5:1265&#x2013;1273. doi: 10.1001/jamacardio.2020.3557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Rio C., Malani P.N. COVID-19-New Insights on a Rapidly Changing Epidemic. JAMA. 2020;323:1339&#x2013;1340. doi: 10.1001/jama.2020.3072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.3072</ArticleId><ArticleId IdType="pubmed">32108857</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>